Literature DB >> 22990925

[Evaluation of safety of video-assisted thoracoscopic esophagectomy for esophageal carcinoma].

Hao Wang1, Li-jie Tan, Jing-pei Li, Ya-xing Shen, Yi Zhang, Ming-xiang Feng, Qun Wang.   

Abstract

OBJECTIVE: To explore the safety of video-assisted thoracoscopic esophagectomy for esophageal carcinoma.
METHODS: From January 2005 to March 2012, 260 patients with esophageal carcinoma received thoracoscopic esophagectomy (TE group), while 322 patients underwent conventional open esophagectomy (OE group). Operative procedures, perioperative complications, reoperation, readmission to intensive care unit (ICU), and perioperative mortality were compared between the two groups.
RESULTS: Compared with OE group, TE group possessed less thoracic operative time [(105±30) min vs. (112±41) min, P=0.000], less blood loss [(95±48) ml vs. (107±44) ml, P=0.002], shorter postoperative hospital stay [(14.3±7.5) d vs. (16.9±9.5) d, P=0.000] and more lymph node harvest from thorax [(13.5±5.0) vs. (11.6±4.7), P=0.000]. The total perioperative complication rate was lower in TE group than that of OE group (34.6% vs. 45.0%, P=0.011), as well as perioperative mortality (0.8% vs. 3.4%, P=0.032). Lower rate of readmission to ICU (5.4% vs. 10.6%, P=0.024) was found in the TE group as compared to the OE group, while the reoperation rate was comparable (1.5% vs. 2.5%, P=0.425).
CONCLUSION: Thoracoscopic esophagectomy is advantageous than open procedure in terms of surgical safety.

Entities:  

Mesh:

Year:  2012        PMID: 22990925

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  2 in total

Review 1.  Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis.

Authors:  Waresijiang Yibulayin; Sikandaer Abulizi; Hongbo Lv; Wei Sun
Journal:  World J Surg Oncol       Date:  2016-12-08       Impact factor: 2.754

2.  Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview.

Authors:  Chengchu Zhu; Ketao Jin
Journal:  Onco Targets Ther       Date:  2013-03-03       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.